Three injections of H19-DTA or P4-DTA (Figure 5) at two-day intervals were able to inhibit tumor development by 49% (P = 0.001) and 55.5% (P = 0.005), respectively compared to H19-Luc and P4-Luc treatments. The gene discussed is H19; the disease is neoplasm.